Browse CATs

Browse CATs  internal medicine  rheumatology  giant cell arteritis

Diagnosis Prognosis Therapy

Giant cell arteritis methotrexate reduces relapse on steroids Level of evidence 1b Expiry Date June 2005 Giant cell arteritis azathioprine had no clear benefit as a steroid-sparing drug. Level of evidence 1b- Expiry Date February 2004 Giant cell arteritis side effects on steroids were common. Level of evidence 4 Expiry Date February 2004 Giant cell arteritis alternate day steroids were less effective but had fewer side effects. Level of evidence 1b Expiry Date February 2004 Giant cell arteritis 20 mg or more of prednisolone was a safer starting dose. Level of evidence 4 Expiry Date March 2004 Giant cell arteritis high dose steroids were not clearly better than low dose. Level of evidence 1b- Expiry Date November 2004 Steroids bisphosphonates reduces loss of lumbar bone mineral density. Level of evidence 1a Expiry Date September 2004 Steroids and long term use bone loss can be prevented with calcium and vitamin D. Level of evidence 1a Expiry Date May 2004